istradefylline analog (NewVac)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameistradefylline analog (NewVac)
Drug Alias Nameselective A2A adenosine receptor antagonist (NewVac)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNewvac Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewvac Llc
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A